Resveratrol Modulates Bone Metabolism Through SIRT1‐Mediated NF‐κB Inhibition: Molecular Mechanisms and Therapeutic Implications
Cell Biochemistry and Function · 2026-11 · 44 (11)
DOI: 10.1002/cbf.70334 ↗At a glance
Übersichtsarbeit in Cell Biochemistry and Function, published online on 2026-11-01. Written by Seyyed Hossein Khatami and 11 co-authors. Institution: Musculoskeletal Injuries Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Major MEDLINE topics: Sirtuin 1, Resveratrol, NF-kappa B, Bone and Bones. 109 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Osteoporosis and associated skeletal pathologies impose a staggering global health burden, disproportionately impacting elderly populations and postmenopausal women. At the root of excessive bone resorption and stalled osteogenesis lie persistent oxidative stress and chronic inflammation. Enter resveratrol, a naturally occurring polyphenol derived from red wine and grapes, which has surfaced as a compelling therapeutic candidate for skeletal preservation owing to its robust antioxidant and anti‐inflammatory capacities. Herein, we evaluate the molecular pathways through which resveratrol governs bone metabolism, focusing sharply on SIRT1‐driven suppression of NF‐κB signaling. Integrating findings across cell cultures, animal models, and clinical trials yields a unified perspective on these osteoprotective mechanisms. Dual benefits define resveratrol's impact on skeletal architecture: it stimulates osteoblast differentiation and mineralization while suppressing osteoclastogenesis and bone resorption. Primarily, these outcomes stem from the activation of SIRT1, a NAD + ‐dependent deacetylase acting as a negative regulator of NF‐κB transcription. Through SIRT1‐mediated deacetylation of the NF‐κB p65 subunit, the transcription of pro‐inflammatory cytokines including IL‐1β, TNF‐α, and IL‐6 diminishes, subsequently dampening RANKL‐driven osteoclastogenesis. Simultaneously, through the SIRT1‐dependent engagement of Nrf2/ARE pathways, antioxidant defenses are bolstered, sparing bone cells from oxidative stress‐induced apoptosis. Substantial preclinical promise notwithstanding, hurdles persist regarding both systemic bioavailability and the standardization of ideal dosing protocols for bone preservation. This review provides a mechanistic framework to evaluate resveratrol as a viable nutraceutical modality for the prevention and management of osteoporosis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Musculoskeletal Injuries Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Orthopedics, Imam Hossein Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Center for Genomics and Personalized Health, Queensland University, Brisbane, Australia.
- School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Australia.
ORCID profiles: Seyyed Hossein Khatami, Alireza Manafi-Rasi, Maryam Fallah, Ahmad Reza Ahmadi Abdashti, Diba Rafienejad, Reza Zandi
Cite
APA
Khatami, S. H., Gouhari, F., Manafi-Rasi, A., Fallah, M., Ehtiati, S., Abdashti, A. R. A., Ariannik, M., Talebi, S., Rafienejad, D., Fakhrzadegan, M., Heidari, P., & Zandi, R. (2026). Resveratrol Modulates Bone Metabolism Through SIRT1‐Mediated NF‐κB Inhibition: Molecular Mechanisms and Therapeutic Implications. Cell Biochemistry and Function, 44(11). https://doi.org/10.1002/cbf.70334
Vancouver
Khatami SH, Gouhari F, Manafi-Rasi A, Fallah M, Ehtiati S, Abdashti ARA, et al. Resveratrol Modulates Bone Metabolism Through SIRT1‐Mediated NF‐κB Inhibition: Molecular Mechanisms and Therapeutic Implications. Cell Biochemistry and Function. 2026;44(11). doi:10.1002/cbf.70334
BibTeX
@article{Khatami2026,
author = {Khatami, Seyyed Hossein and Gouhari, Faezeh and Manafi-Rasi, Alireza and Fallah, Maryam and Ehtiati, Sajad and Abdashti, Ahmad Reza Ahmadi and Ariannik, Mohsen and Talebi, Shahin and Rafienejad, Diba and Fakhrzadegan, Mina and Heidari, Parasta and Zandi, Reza},
title = {Resveratrol Modulates Bone Metabolism Through SIRT1‐Mediated NF‐κB Inhibition: Molecular Mechanisms and Therapeutic Implications},
journal = {Cell Biochemistry and Function},
year = {2026},
volume = {44},
number = {11},
doi = {10.1002/cbf.70334}
}
EUVIMED